{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:22:59Z","timestamp":1740374579535,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.7759\/cureus.79514","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T18:22:01Z","timestamp":1740334921000},"source":"Crossref","is-referenced-by-count":0,"title":["Feasibility of Proton Beam Therapy for Para-Aortic Lymph Node Recurrence in Patients With Gynecologic Cancer After Pelvic Irradiation: A Case Series"],"prefix":"10.7759","author":[{"given":"Yuka","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayumi","family":"Shikama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Fujieda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroya","family":"Itagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuri","family":"Tenjimbayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsukasa","family":"Saida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toyomi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.034","article-title":"Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study","volume":"103","author":"Niibe Y","year":"2006","unstructured":"Niibe Y, Kazumoto T, Toita T, et al.. Frequency and characteristics of isolated para-aortic lymph node recurrence in patients with uterine cervical carcinoma in Japan: a multi-institutional study. Gynecol Oncol. 2006, 103:435-8. 10.1016\/j.ygyno.2006.03.034","journal-title":"Gynecol Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2010.11.026","article-title":"The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients","volume":"121","author":"Chiang AJ","year":"2011","unstructured":"Chiang AJ, Yu KJ, Chao KC, Teng NN. The incidence of isolated para-aortic nodal metastasis in completely staged endometrial cancer patients. Gynecol Oncol. 2011, 121:122-5. 10.1016\/j.ygyno.2010.11.026","journal-title":"Gynecol Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.10.002","article-title":"Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer","volume":"132","author":"Kumar S","year":"2014","unstructured":"Kumar S, Podratz KC, Bakkum-Gamez JN, et al.. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. Gynecol Oncol. 2014, 132:38-43. 10.1016\/j.ygyno.2013.10.002","journal-title":"Gynecol Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2020.06.007","article-title":"ESTRO\/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer","volume":"24","author":"Calvo FA","year":"2020","unstructured":"Calvo FA, Sole CV, Rutten HJ, et al.. ESTRO\/ACROP IORT recommendations for intraoperative radiation therapy in locally recurrent rectal cancer. Clin Transl Radiat Oncol. 2020, 24:41-8. 10.1016\/j.ctro.2020.06.007","journal-title":"Clin Transl Radiat Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-017-1190-2","article-title":"A systematic review of publications on charged particle therapy for hepatocellular carcinoma","volume":"23","author":"Igaki H","year":"2018","unstructured":"Igaki H, Mizumoto M, Okumura T, Hasegawa K, Kokudo N, Sakurai H. A systematic review of publications on charged particle therapy for hepatocellular carcinoma. Int J Clin Oncol. 2018, 23:423-33. 10.1007\/s10147-017-1190-2","journal-title":"Int J Clin Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2019.03.012","article-title":"Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer","volume":"136","author":"Hiroshima Y","year":"2019","unstructured":"Hiroshima Y, Fukumitsu N, Saito T, et al.. Concurrent chemoradiotherapy using proton beams for unresectable locally advanced pancreatic cancer. Radiother Oncol. 2019, 136:37-43. 10.1016\/j.radonc.2019.03.012","journal-title":"Radiother Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/0284186X.2016.1205218","article-title":"Proton radiotherapy for gynecologic neoplasms","volume":"55","author":"Verma V","year":"2016","unstructured":"Verma V, Simone CB 2nd, Wahl AO, Beriwal S, Mehta MP. Proton radiotherapy for gynecologic neoplasms. Acta Oncol. 2016, 55:1257-65. 10.1080\/0284186X.2016.1205218","journal-title":"Acta Oncol"},{"key":"ref8","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) v4.0. (2009). Accessed. December 26, 2024: https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/ctc.htm#ctc_40."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer EA","year":"2009","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, et al.. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009, 45:228-47. 10.1016\/j.ejca.2008.10.026","journal-title":"Eur J Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602754","article-title":"Proton beam therapy","volume":"93","author":"Levin WP","year":"2005","unstructured":"Levin WP, Kooy H, Loeffler JS, DeLaney TF. Proton beam therapy. Br J Cancer. 2005, 93:849-54. 10.1038\/sj.bjc.6602754","journal-title":"Br J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.07.012","article-title":"Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies","volume":"82","author":"Milby AB","year":"2012","unstructured":"Milby AB, Both S, Ingram M, Lin LL. Dosimetric comparison of combined intensity-modulated radiotherapy (IMRT) and proton therapy versus IMRT alone for pelvic and para-aortic radiotherapy in gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2012, 82:e477-84. 10.1016\/j.ijrobp.2011.07.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.01.004","article-title":"Treatment tolerability and toxicity of postoperative proton beam therapy for gynecologic malignancies: results of the prospective phase 2 APROVE trial","volume":"116","author":"Arians N","year":"2023","unstructured":"Arians N, Lindel K, Krisam J, et al.. Treatment tolerability and toxicity of postoperative proton beam therapy for gynecologic malignancies: results of the prospective phase 2 APROVE trial. Int J Radiat Oncol Biol Phys. 2023, 116:825-36. 10.1016\/j.ijrobp.2023.01.004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.11.040","article-title":"Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging","volume":"79","author":"Hayman JA","year":"2011","unstructured":"Hayman JA, Callahan JW, Herschtal A, Everitt S, Binns DS, Hicks RJ, Mac Manus M. Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging. Int J Radiat Oncol Biol Phys. 2011, 79:847-52. 10.1016\/j.ijrobp.2009.11.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.adro.2022.100998","article-title":"Predictors of acute hematologic toxicity in women receiving extended-field chemoradiation for cervical cancer: do known pelvic radiation bone marrow constraints apply?","volume":"7","author":"Hara JH","year":"2022","unstructured":"Hara JH, Jutzy JM, Arya R, et al.. Predictors of acute hematologic toxicity in women receiving extended-field chemoradiation for cervical cancer: do known pelvic radiation bone marrow constraints apply?. Adv Radiat Oncol. 2022, 7:100998. 10.1016\/j.adro.2022.100998","journal-title":"Adv Radiat Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0090-8258(87)90297-6","article-title":"Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract","volume":"27","author":"Russell AH","year":"1987","unstructured":"Russell AH, Koh WJ, Markette K, et al.. Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract. Gynecol Oncol. 1987, 27:226-32. 10.1016\/0090-8258(87)90297-6","journal-title":"Gynecol Oncol"},{"key":"ref16","article-title":"Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of the Korean Radiation Oncology Group (KROG 14-11)","volume":"35","author":"Park HJ","year":"2015","unstructured":"Park HJ, Chang AR, Seo Y, Cho CK, Jang WI, Kim MS, Choi C. Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of the Korean Radiation Oncology Group (KROG 14-11). Anticancer Res. 2015, 35:5103-10.","journal-title":"Anticancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2019.05.012","article-title":"Salvage curative-intent reirradiation stereotactic body radiation therapy for isolated pelvic and\/or paraortic recurrences of gynecologic malignancies","volume":"9","author":"Ling DC","year":"2019","unstructured":"Ling DC, Vargo JA, Burton SA, Heron DE, Beriwal S. Salvage curative-intent reirradiation stereotactic body radiation therapy for isolated pelvic and\/or paraortic recurrences of gynecologic malignancies. Pract Radiat Oncol. 2019, 9:418-25. 10.1016\/j.prro.2019.05.012","journal-title":"Pract Radiat Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/337418-feasibility-of-proton-beam-therapy-for-para-aortic-lymph-node-recurrence-in-patients-with-gynecologic-cancer-after-pelvic-irradiation-a-case-series","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T18:22:04Z","timestamp":1740334924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/337418-feasibility-of-proton-beam-therapy-for-para-aortic-lymph-node-recurrence-in-patients-with-gynecologic-cancer-after-pelvic-irradiation-a-case-series"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.79514","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}